Understanding End-of-Life Care Among Adolescents, Young Adults with Cancer

Share this content:

the Cancer Therapy Advisor take:

Most adolescents and young adults (AYAs) with cancer received medically intensive end-of-life (EOL) care measures, according to an article published online in the journal JAMA Oncology.

The authors studied the health records of 663 AYAs who were diagnosed with either stage 1 to 3 cancer and evidence of recurrence or stage 4 cancer in the Kaiser Permanente Southern California (KSPC) registry. All patients died before the age of 40 (time of death age range, 15-39 years) between 2001 and 2010.

Results showed 72 (11%) out of the 663 patients were administered chemotherapy within 14 days of death. One hundred forty-four (22%) of AYAs were admitted to the intensive care unit, 147 (22%) visited the emergency department more than once, and 413 (62%) had a hospitalization in the last 30 days of life.

Furthermore, 449 of the 663 (68%) AYA patients with cancer received at least one medically intensive EOL care measure.

The study advocates for a better understanding of EOL care in the AYA population.

Understanding End-of-Life Care Among Adolescents, Young Adults with Cancer
Most adolescents and young adults with cancer received medically intensive end-of-life care measures.
Cancer is the leading disease-related cause of death among adolescents and young adults, but little is known about the care that AYA patients with cancer receive at the end of life.
READ FULL ARTICLE From oncology.jamanetwork.com

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs